| Catalog No. | HV999026 |
|---|
| Species reactivity | Human |
|---|
| Applications | Research Grade Biosimilar |
|---|
| Host species | Humanized |
|---|
| Isotype | IgG1(VH-CH1-h)-scFv_L-kappa-scFv |
|---|
| Expression system | Mammalian Cells |
|---|
| Clonality | Monoclonal |
|---|
| Target | Interleukin-22, Cytokine Zcyto18, IL-22, ZCYTO18, IL22, ILTIF, IL-TIF, IL-10-related T-cell-derived-inducible factor, IL13, NC30, Interleukin-13, IL-13, ALB, Albumin |
|---|
| Concentration | 1mg/ml |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G, purified from cell culture supernatant. |
|---|
| Accession | Q9GZX6 & P35225 & P02768 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS,pH7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -2207°C. |
|---|
| Alternate Names | Trispecific,Trivalent,CAS:2765066-99-5 |
|---|
| Background | Donzakimig is an anti-IL13/IL22/ALB monoclonal antibody. |
|---|
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|---|
